{"id":1647,"date":"2017-11-12T16:08:35","date_gmt":"2017-11-12T16:08:35","guid":{"rendered":"https:\/\/ring20researchsupport.co.uk\/?p=1647"},"modified":"2023-02-10T08:54:20","modified_gmt":"2023-02-10T08:54:20","slug":"crdn-summit-2017-2","status":"publish","type":"post","link":"https:\/\/ring20researchsupport.co.uk\/fr\/2017\/11\/crdn-summit-2017-2\/","title":{"rendered":"Sommet CRDN 2017"},"content":{"rendered":"<p>Le 23 octobre, Dawn et Allison ont eu la fantastique opportunit\u00e9 d&#039;assister au sommet 2017 du Cambridge Rare Disease Network (CRDN) au Robinson College de Cambridge.<\/p>\n<p>\u00c0 notre arriv\u00e9e, nous avons remis nos affiches sur le parcours des patients (voir ci-dessous) et nous sommes connect\u00e9s \u00e0 une nouvelle technologie pour suivre la conf\u00e9rence sur nos t\u00e9l\u00e9phones\/tablettes, dans l&#039;auditorium. La nouvelle technologie Glisser nous a permis de suivre toutes les diapositives des intervenants sur nos appareils, et\/ou de prendre des notes personnelles, de poser des questions de mani\u00e8re interactive pendant les conf\u00e9rences (ainsi que de voir les questions post\u00e9es par d&#039;autres et de les \u00ab aimer \u00bb) et de publier des diapositives avec commente directement sur <em>Twitter<\/em>. C&#039;\u00e9tait une innovation technique plut\u00f4t cool, voire un peu mouvement\u00e9e pour tout suivre\u00a0!<\/p>\n<div id='gallery-1' class='gallery galleryid-1647 gallery-columns-4 gallery-size-thumbnail'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/crdn-opening\/'><img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/CRDN-opening-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" aria-describedby=\"gallery-1-1651\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/CRDN-opening-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/CRDN-opening-100x100.jpg 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1651'>\n\t\t\t\tAccueillir\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/?attachment_id=1660'><img decoding=\"async\" width=\"150\" height=\"21\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_652_2021-03-11-18-01-35_aff0cb2.png\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_652_2021-03-11-18-01-35_aff0cb2.png 1200w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_652_2021-03-11-18-01-35_aff0cb2-600x83.png 600w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/unravel\/unravel-2\/'><img decoding=\"async\" width=\"150\" height=\"145\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/unravel-150x145.png\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/?attachment_id=1662'><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"7\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_1123_2021-03-11-18-02-28_4b6acba4.png\" class=\"attachment-thumbnail size-thumbnail\" alt=\"\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_1123_2021-03-11-18-02-28_4b6acba4.png 1200w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_1123_2021-03-11-18-02-28_4b6acba4-600x28.png 600w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/a>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>\n\n<p>L&#039;\u00e9v\u00e9nement a \u00e9t\u00e9 ouvert par Alistair Kent OBE, pr\u00e9sident du CRDN.<\/p>\n<p>Nous avons appr\u00e9ci\u00e9 les pr\u00e9sentations de deux groupes de soutien aux patients\u00a0:<\/p>\n<ul>\n<li>Kay Parkinson, PDG du CRDN et d&#039;Alstrom Europe, qui a inspir\u00e9 le concours d&#039;affiches sur le parcours du patient, car auparavant, une pr\u00e9sentation fortuite d&#039;affiches par Kay avait conduit \u00e0 une collaboration pour d\u00e9velopper un traitement m\u00e9dicamenteux pour le syndrome d&#039;Alstrom.<\/li>\n<li>Daniel Lewi, PDG de la CATs Foundation et de nouvelles recherches sur les maladies de Tay-Sachs et Sandhoff en cours \u00e0 Cambridge<\/li>\n<\/ul>\n<p><strong>Le concours d\u2019affiches sur le parcours du patient<\/strong><\/p>\n<p>Une grande innovation de la conf\u00e9rence et un v\u00e9ritable moment fort pour nous ont \u00e9t\u00e9 le concours d&#039;affiches sur le parcours du patient. Avant la conf\u00e9rence, nous \u00e9tions l&#039;un des 33 groupes de patients diff\u00e9rents qui ont pris le temps de produire des affiches pour r\u00e9sumer leur maladie rare et leur propre parcours de patient. Je (Allison) n&#039;ai jamais produit d&#039;affiche auparavant et n&#039;ai aucune exp\u00e9rience en conception graphique, mais avec les conseils de la charmante \u00e9quipe du CRDN, j&#039;ai essay\u00e9, car je sentais que l&#039;importance \u00e9tait de faire conna\u00eetre le syndrome r(20). , <em>comment cela nous affecte et ce que nous voulons<\/em>, <span style=\"text-decoration: underline;\">pas<\/span> la qualit\u00e9 de mes cr\u00e9ations !<\/p>\n\n<p>Les affiches ont \u00e9t\u00e9 partag\u00e9es avec tous les d\u00e9l\u00e9gu\u00e9s sous forme imprim\u00e9e afin que chacun, qu&#039;il soit clinicien, chercheur, travailleur des sciences de la vie ou patient atteint d&#039;une maladie rare, puisse tout savoir sur l&#039;impact d&#039;une multitude de maladies rares. Le CRDN pr\u00e9voit \u00e9galement de continuer \u00e0 faire circuler nos affiches lors d&#039;\u00e9v\u00e9nements futurs au cours des prochains mois, la port\u00e9e de la sensibilisation est donc \u00e9norme.<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1578\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-300x225.jpg\" alt=\"Ring20 Research and Support UK CIO final\" width=\"300\" height=\"225\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-300x225.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-scaled-600x450.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-1024x768.jpg 1024w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-768x576.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-1536x1152.jpg 1536w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-2048x1536.jpg 2048w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO-final-16x12.jpg 16w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<a href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1579\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-300x169.jpg\" alt=\"Ring20 Research and Support UK CIO_Patient journeyDW\" width=\"300\" height=\"169\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-300x169.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-600x338.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-1024x576.jpg 1024w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-768x432.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW-16x9.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/10\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW.jpg 1280w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Vous pouvez t\u00e9l\u00e9charger une copie de notre affiche et\/ou du parcours du patient ci-dessous\u00a0:<\/p>\n<ul>\n<li><a title=\"Anneau20 Constitution\" href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2016\/03\/ConstitutionCIO.pdf\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2016\/04\/Adobe_PDF_file_icon_32x32.png\" alt=\"PDF icon\"><\/a>&nbsp;<a href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Ring20-Research-and-Support-UK-CIO-final.pdf\">Affiche (meilleur format A0 imprim\u00e9)<\/a><\/li>\n<li><a href=\"\/wp-content\/uploads\/2015\/01\/Child-Protection-Policy001.pdf\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2016\/04\/Adobe_PDF_file_icon_32x32.png\" alt=\"PDF icon\"><\/a>&nbsp;<a href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Ring20-Research-and-Support-UK-CIO_Patient-journeyDW.pdf\">Parcours des patients<\/a><\/li>\n<\/ul>\n<p>Plus int\u00e9ressant encore, cinq auteurs d&#039;affiches ont \u00e9t\u00e9 s\u00e9lectionn\u00e9s pour donner un expos\u00e9 \u00e9clair de cinq minutes pendant la conf\u00e9rence, racontant un peu au public leur condition et leurs trois souhaits pour l&#039;avenir. Malheureusement, notre affiche n&#039;a pas \u00e9t\u00e9 pr\u00e9s\u00e9lectionn\u00e9e car nous \u00e9tions confront\u00e9s \u00e0 une concurrence tr\u00e8s rude, mais c&#039;\u00e9tait formidable d&#039;entendre leurs souhaits, qui \u00e9taient souvent pertinents pour tous !<\/p>\n<p>L\u2019ensemble de l\u2019\u00e9v\u00e9nement a \u00e9t\u00e9 une formidable vitrine pour les maladies rares et certaines des derni\u00e8res innovations. Il y a eu des discussions sur :<\/p>\n<ul>\n<li>D\u00e9veloppement de m\u00e9dicaments orphelins (m\u00e9dicaments contre les maladies rares) par Sobi, une soci\u00e9t\u00e9 pharmaceutique qui pr\u00e9tend \u00ab \u00e9couter les communaut\u00e9s de patients \u00bb<\/li>\n<li>la r\u00e9utilisation de m\u00e9dicaments\u00a0; nous avons entendu le Dr Rick Thompson de Findacure qui a sugg\u00e9r\u00e9 que \u00ab l&#039;avenir est la r\u00e9utilisation des m\u00e9dicaments \u00bb, \u00e9tant donn\u00e9 que le co\u00fbt de mise sur le march\u00e9 de nouveaux m\u00e9dicaments est en constante augmentation et que le nombre de nouveaux m\u00e9dicaments d\u00e9velopp\u00e9s est en d\u00e9clin. Rick a donn\u00e9 une explication tr\u00e8s simple de ce qu\u2019est la r\u00e9utilisation d\u2019un m\u00e9dicament\u00a0:<\/li>\n<\/ul>\n<p style=\"text-align: center;\"><a href=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Drug-repurposing1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1652\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Drug-repurposing1-300x169.jpg\" alt=\"Drug repurposing1\" width=\"300\" height=\"169\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Drug-repurposing1-300x169.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Drug-repurposing1-16x9.jpg 16w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/Drug-repurposing1.jpg 481w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<ul>\n<li>l&#039;\u00e9dition g\u00e9n\u00e9tique qui peut gu\u00e9rir certaines maladies rares (actuellement utilis\u00e9e pour des g\u00e8nes uniques sp\u00e9cifiques uniquement \u00e0 ce stade, donc non applicable au syndrome r(20), mais un concept \u00e9tonnant tout de m\u00eame\u00a0!)<\/li>\n<li>la \u00ab r\u00e9volution des patients impatients \u00bb et le pouvoir des groupes de soutien aux patients<\/li>\n<li>l\u2019av\u00e8nement de la t\u00e9l\u00e9m\u00e9decine et la n\u00e9cessit\u00e9 d\u2019un r\u00e9seau d\u2019infirmi\u00e8res sp\u00e9cialis\u00e9es dans les maladies rares.<\/li>\n<li>Mendelian \u2013 un nouveau moteur de recherche puissant sur les maladies rares destin\u00e9 aux professionnels de la sant\u00e9<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\">Une question cl\u00e9 a \u00e9t\u00e9 pos\u00e9e au public :<\/p>\n<p style=\"text-align: center;\"><strong>Comment pouvons-nous int\u00e9grer #RareDisease au grand public\u00a0? <\/strong><\/p>\n<p style=\"text-align: center;\"><strong>Campagne TV, changer le langage de la maladie, <\/strong><\/p>\n<p style=\"text-align: center;\"><strong>#education choisir le bon m\u00e9dia Formation GP\u2026<\/strong><\/p>\n<p style=\"text-align: center;\"><em>Saviez-vous que les maladies rares sont plus courantes que le cancer et le sida r\u00e9unis\u00a0?<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>\u00c0 la fin de la journ\u00e9e, il y avait du temps pour un verre de vin bien m\u00e9rit\u00e9 pour r\u00e9fl\u00e9chir sur la journ\u00e9e avec tous les participants et une chance de rencontrer un groupe formidable de personnes partageant les m\u00eames id\u00e9es \u2013 des repr\u00e9sentants d&#039;autres groupes de soutien aux patients ; nous nous appelons les \u00ab\u00a0R\u00e9volutionnaires rares\u00a0\u00bb car nous sommes tous abonn\u00e9s au magazine Rare Revolution et sommes des d\u00e9fenseurs du changement dans nos propres maladies rares\u00a0! Nous avons h\u00e2te de nous retrouver lors de prochains \u00e9v\u00e9nements et de rester en contact sur les r\u00e9seaux sociaux. Ces gars-l\u00e0 nous apprennent tellement de choses et le pouvoir du partage d\u2019informations et du r\u00e9seautage est inestimable.<\/p>\n<p>Vivement la r\u00e9volution rare !<\/p>\n<div id='gallery-3' class='gallery galleryid-1647 gallery-columns-2 gallery-size-medium'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/rare-revolutionaries-crdn-2017\/'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-300x300.jpg\" class=\"attachment-medium size-medium\" alt=\"\" aria-describedby=\"gallery-3-1649\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-300x300.jpg 300w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-100x100.jpg 100w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-600x600.jpg 600w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-150x150.jpg 150w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-768x768.jpg 768w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017-12x12.jpg 12w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/rare-revolutionaries-CRDN-2017.jpg 960w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-3-1649'>\n\t\t\t\tLes rares r\u00e9volutionnaires !\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='https:\/\/ring20researchsupport.co.uk\/fr\/?attachment_id=1661'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"64\" src=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_684_2021-03-11-18-02-09_1837ce74.png\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_684_2021-03-11-18-02-09_1837ce74.png 1200w, https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/elementor\/screenshots\/Elementor-post-screenshot_684_2021-03-11-18-02-09_1837ce74-600x129.png 600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Le 23 octobre, Dawn et Allison ont eu la fantastique opportunit\u00e9 d&#039;assister au sommet 2017 du Cambridge Rare Disease Network (CRDN) au Robinson College de Cambridge.<\/p>","protected":false},"author":3,"featured_media":4121,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[17,19],"tags":[],"class_list":["post-1647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRDN Summit 2017 - Ring20 Research and Support UK CIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ring20researchsupport.co.uk\/fr\/2017\/11\/crdn-summit-2017-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRDN Summit 2017 - Ring20 Research and Support UK CIO\" \/>\n<meta property=\"og:description\" content=\"On 23rd Oct, Dawn and Allison had the fantastic opportunity to attend the Cambridge Rare Disease Network (CRDN) Summit 2017 at Robinson College, Cambridge\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ring20researchsupport.co.uk\/fr\/2017\/11\/crdn-summit-2017-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Ring20 Research and Support UK CIO\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-12T16:08:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T08:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"710\" \/>\n\t<meta property=\"og:image:height\" content=\"410\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alison\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alison\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/\"},\"author\":{\"name\":\"Alison\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\"},\"headline\":\"CRDN Summit 2017\",\"datePublished\":\"2017-11-12T16:08:35+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/\"},\"wordCount\":770,\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/crdn-AandD-710x410-1.jpg\",\"articleSection\":[\"Blog\",\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/\",\"name\":\"CRDN Summit 2017 - Ring20 Research and Support UK CIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/crdn-AandD-710x410-1.jpg\",\"datePublished\":\"2017-11-12T16:08:35+00:00\",\"dateModified\":\"2023-02-10T08:54:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/crdn-AandD-710x410-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/crdn-AandD-710x410-1.jpg\",\"width\":710,\"height\":410},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/2017\\\/11\\\/crdn-summit-2017-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRDN Summit 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"name\":\"Ring20 Research and Support UK CIO\",\"description\":\"Promoting research, education and continuous support to end undiagnosed and misdiagnosed Ring20 epilepsy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#organization\",\"name\":\"Ring20 Research and Support CIO\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"contentUrl\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Ring20_logo-high-resolution.jpg\",\"width\":2357,\"height\":666,\"caption\":\"Ring20 Research and Support CIO\"},\"image\":{\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/#\\\/schema\\\/person\\\/26816b7c1c7561b936befe247794dcac\",\"name\":\"Alison\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g\",\"caption\":\"Alison\"},\"url\":\"https:\\\/\\\/ring20researchsupport.co.uk\\\/fr\\\/author\\\/alison\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sommet CRDN 2017 - Ring20 Research and Support UK CIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ring20researchsupport.co.uk\/fr\/2017\/11\/crdn-summit-2017-2\/","og_locale":"fr_FR","og_type":"article","og_title":"CRDN Summit 2017 - Ring20 Research and Support UK CIO","og_description":"On 23rd Oct, Dawn and Allison had the fantastic opportunity to attend the Cambridge Rare Disease Network (CRDN) Summit 2017 at Robinson College, Cambridge","og_url":"https:\/\/ring20researchsupport.co.uk\/fr\/2017\/11\/crdn-summit-2017-2\/","og_site_name":"Ring20 Research and Support UK CIO","article_published_time":"2017-11-12T16:08:35+00:00","article_modified_time":"2023-02-10T08:54:20+00:00","og_image":[{"width":710,"height":410,"url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg","type":"image\/jpeg"}],"author":"Alison","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Alison","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#article","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/"},"author":{"name":"Alison","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac"},"headline":"CRDN Summit 2017","datePublished":"2017-11-12T16:08:35+00:00","dateModified":"2023-02-10T08:54:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/"},"wordCount":770,"publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg","articleSection":["Blog","Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/","url":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/","name":"Sommet CRDN 2017 - Ring20 Research and Support UK CIO","isPartOf":{"@id":"https:\/\/ring20researchsupport.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#primaryimage"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg","datePublished":"2017-11-12T16:08:35+00:00","dateModified":"2023-02-10T08:54:20+00:00","breadcrumb":{"@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#primaryimage","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2017\/11\/crdn-AandD-710x410-1.jpg","width":710,"height":410},{"@type":"BreadcrumbList","@id":"https:\/\/ring20researchsupport.co.uk\/2017\/11\/crdn-summit-2017-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ring20researchsupport.co.uk\/"},{"@type":"ListItem","position":2,"name":"CRDN Summit 2017"}]},{"@type":"WebSite","@id":"https:\/\/ring20researchsupport.co.uk\/#website","url":"https:\/\/ring20researchsupport.co.uk\/","name":"Ring20 Research and Support DSI Royaume-Uni","description":"Promouvoir la recherche, l&#039;\u00e9ducation et le soutien continu pour mettre fin \u00e0 l&#039;\u00e9pilepsie Ring20 non diagnostiqu\u00e9e et mal diagnostiqu\u00e9e","publisher":{"@id":"https:\/\/ring20researchsupport.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ring20researchsupport.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ring20researchsupport.co.uk\/#organization","name":"DSI de la recherche et du support Ring20","url":"https:\/\/ring20researchsupport.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","contentUrl":"https:\/\/ring20researchsupport.co.uk\/wp-content\/uploads\/2021\/03\/Ring20_logo-high-resolution.jpg","width":2357,"height":666,"caption":"Ring20 Research and Support CIO"},"image":{"@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ring20researchsupport.co.uk\/#\/schema\/person\/26816b7c1c7561b936befe247794dcac","name":"Alison","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ade8313c3cbccc4f3dab7d41f7722b149cb238832a224128ffac0ebf12935eaa?s=96&d=mm&r=g","caption":"Alison"},"url":"https:\/\/ring20researchsupport.co.uk\/fr\/author\/alison\/"}]}},"_links":{"self":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/1647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/comments?post=1647"}],"version-history":[{"count":1,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/1647\/revisions"}],"predecessor-version":[{"id":10385,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/posts\/1647\/revisions\/10385"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/media\/4121"}],"wp:attachment":[{"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/media?parent=1647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/categories?post=1647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ring20researchsupport.co.uk\/fr\/wp-json\/wp\/v2\/tags?post=1647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}